WallStreetZenWallStreetZen

NASDAQ: AQST
Aquestive Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for AQST

Based on 3 analysts offering 12 month price targets for Aquestive Therapeutics Inc.
Min Forecast
$4.00+55.64%
Avg Forecast
$6.00+133.46%
Max Forecast
$8.00+211.28%

Should I buy or sell AQST stock?

Based on 3 analysts offering ratings for Aquestive Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
3 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AQST stock forecasts and price targets.

AQST stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-08
lockedlocked$00.00+00.00%2023-10-10
lockedlocked$00.00+00.00%2023-09-21

1 of 1

Forecast return on equity

Is AQST forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.62%

Forecast return on assets

Is AQST forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

AQST revenue forecast

What is AQST's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$48.4M+0.69%
Avg 2 year Forecast
$55.8M+16.19%
Avg 3 year Forecast
$78.6M+63.47%
AQST's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AQST revenue growth forecast

How is AQST forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
16.35%
Industry
9.28%
Market
10%
AQST's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AQST's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AQST vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
AQST$2.57$6.00+133.46%Buy
OPTN$1.56N/AN/A
ALIM$3.37N/AN/A
OGI$2.02N/AN/A
ACB$3.26N/AN/A

Aquestive Therapeutics Stock Forecast FAQ

Is Aquestive Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: AQST) stock is to Buy AQST stock.

Out of 3 analysts, 0 (0%) are recommending AQST as a Strong Buy, 3 (100%) are recommending AQST as a Buy, 0 (0%) are recommending AQST as a Hold, 0 (0%) are recommending AQST as a Sell, and 0 (0%) are recommending AQST as a Strong Sell.

If you're new to stock investing, here's how to buy Aquestive Therapeutics stock.

What is AQST's revenue growth forecast for 2024-2026?

(NASDAQ: AQST) Aquestive Therapeutics's forecast annual revenue growth rate of 16.35% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.28%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10%.

Aquestive Therapeutics's revenue in 2024 is $48,059,000.On average, 3 Wall Street analysts forecast AQST's revenue for 2024 to be $3,230,868,824, with the lowest AQST revenue forecast at $2,537,156,754, and the highest AQST revenue forecast at $3,772,351,490. On average, 1 Wall Street analysts forecast AQST's revenue for 2025 to be $3,728,285,083, with the lowest AQST revenue forecast at $3,728,285,083, and the highest AQST revenue forecast at $3,728,285,083.

In 2026, AQST is forecast to generate $5,245,237,752 in revenue, with the lowest revenue forecast at $5,245,237,752 and the highest revenue forecast at $5,245,237,752.

What is AQST's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: AQST) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of N/A.

What is AQST's Price Target?

According to 3 Wall Street analysts that have issued a 1 year AQST price target, the average AQST price target is $6.00, with the highest AQST stock price forecast at $8.00 and the lowest AQST stock price forecast at $4.00.

On average, Wall Street analysts predict that Aquestive Therapeutics's share price could reach $6.00 by Nov 8, 2024. The average Aquestive Therapeutics stock price prediction forecasts a potential upside of 133.46% from the current AQST share price of $2.57.

What is AQST's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: AQST) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.